From: The T4/T3 quotient as a risk factor for differentiated thyroid cancer: a case control study
Cases | Controls | p-value | |||||
---|---|---|---|---|---|---|---|
Average | Confidence interval | Average | Confidence interval | Amount | |||
All Patients | |||||||
TSH | 2.25 | 0.360 | 140 | 2.36 | 1.68 | 84 | 0.874 |
fT4 | 14.8 | 0.689 | 131 | 14.3 | 1.71 | 77 | 0.478 |
fT3 | 4.63 | 0.465 | 80 | 5.27 | 0.946 | 48 | 0.199 |
fT4/fT3 | 3.85 | 0.206 | 75 | 2.94 | 0.467 | 42 | 0.047 |
2−2.9 cm Nodule | |||||||
TSH | 2.42 | 0.77 | 40 | 1.98 | 0.55 | 20 | 0.089 |
fT4 | 15.24 | 1.53 | 37 | 13.08 | 1.28 | 18 | 0.079 |
fT3 | 5.30 | 1.73 | 20 | 4.86 | 0.23 | 11 | 0.713 |
fT4/fT3 | 3.47 | 0.47 | 18 | 2.85 | 0.33 | 9 | 0.096 |
3−3.9 cm Nodule | |||||||
TSH | 2.37 | 0.74 | 30 | 1.70 | 1.02 | 20 | 0.283 |
fT4 | 14.83 | 1.71 | 27 | 13.84 | 0.97 | 18 | 0.388 |
fT3 | 4.39 | 0.38 | 14 | 4.74 | 0.41 | 11 | 0.223 |
fT4/fT3 | 3.36 | 0.59 | 13 | 3.10 | 0.49 | 11 | 0.520 |
>3.9 cm Nodule | |||||||
TSH | 2.64 | 1.18 | 25 | 1.64 | 0.41 | 20 | 0.202 |
fT4 | 15.10 | 1.47 | 24 | 14.36 | 0.64 | 17 | 0.475 |
fT3 | 4.62 | 0.63 | 13 | 5.15 | 0.26 | 10 | 0.233 |
fT4/fT3 | 3.35 | 0.40 | 12 | 2.97 | 0.17 | 9 | 0.133 |